Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,305	1,245	918.33	1,159	744.66	855.77
Cash & Short-Term Investments	1,305	1,245	918.33	1,159	744.66	855.77
Cash Growth	41.49%	35.57%	-20.75%	55.61%	-12.98%	23.94%
Accounts Receivable	1,379	1,120	949.16	970.63	870.46	518.55
Other Receivables	18.47	9.5	9.34	12.65	17.42	25.16
Receivables	1,397	1,129	958.5	983.28	887.87	543.71
Inventory	1,178	1,273	1,313	1,212	1,028	1,124
Prepaid Expenses	-	0.03	3.41	-	-	7.15
Other Current Assets	119.19	79.78	121.1	102.95	93.88	155.88
Total Current Assets	3,999	3,727	3,314	3,457	2,754	2,687
Property, Plant & Equipment	4,307	4,296	4,061	4,000	3,766	3,539
Long-Term Investments	293.43	306.42	241.37	239.18	260.2	316.62
Other Intangible Assets	549.66	565.04	494.94	474.11	466.45	449.25
Long-Term Deferred Tax Assets	22.36	24.92	23.48	15.62	15.17	23.52
Long-Term Deferred Charges	8.81	9.99	14.46	8.61	10.54	11.92
Other Long-Term Assets	89.07	90.75	136.77	69.85	59.99	65.93
Total Assets	9,270	9,020	8,286	8,265	7,332	7,093
Accounts Payable	1,207	1,159	1,178	1,090	1,066	742.9
Accrued Expenses	54.34	137.28	203.11	159.43	122.35	144.87
Short-Term Debt	496.69	580.16	283.96	118.02	269.46	200.42
Current Portion of Long-Term Debt	-	312.26	271.97	714.77	421.03	356.55
Current Portion of Leases	-	1.4	1.78	2.69	2.8	1.56
Current Income Taxes Payable	21.51	6.69	5.03	7.99	12.2	4.42
Current Unearned Revenue	72.87	96.84	149.14	593.26	100.4	377.79
Other Current Liabilities	1,382	502.3	393.16	472.23	507.26	552.53
Total Current Liabilities	3,235	2,796	2,486	3,158	2,502	2,381
Long-Term Debt	398.34	771.54	799.4	545.66	946.2	1,063
Long-Term Leases	1.17	1.11	1.58	2.72	6.77	23.93
Long-Term Unearned Revenue	78.75	83.25	100.67	118.37	133.97	146.5
Long-Term Deferred Tax Liabilities	140.78	122.53	99.21	66.44	65.61	69.31
Other Long-Term Liabilities	26.06	28.06	23.56	23.56	26.46	18.14
Total Liabilities	3,880	3,802	3,510	3,915	3,681	3,702
Common Stock	689.78	682.41	674.68	669.63	627.37	621.86
Additional Paid-In Capital	1,196	1,145	1,055	998.14	677.94	644.91
Retained Earnings	3,101	2,989	2,706	2,345	2,034	1,780
Comprehensive Income & Other	168.91	175.86	117.01	113.68	128.37	177.21
Total Common Equity	5,156	4,992	4,553	4,126	3,468	3,224
Minority Interest	234.43	225.91	222.65	223.29	183.2	167.5
Shareholders' Equity	5,390	5,218	4,776	4,350	3,651	3,391
Total Liabilities & Equity	9,270	9,020	8,286	8,265	7,332	7,093
Total Debt	896.2	1,666	1,359	1,384	1,646	1,645
Net Cash (Debt)	408.37	-421.45	-440.36	-225.11	-901.58	-789.42
Net Cash Per Share	0.58	-0.61	-0.64	-0.34	-1.44	-1.26
Filing Date Shares Outstanding	747.3	689.78	682.41	669.63	627.37	627.37
Total Common Shares Outstanding	747.3	682.41	674.68	669.63	627.37	621.86
Working Capital	764.59	931.23	828.33	298.47	252.08	305.83
Book Value Per Share	6.90	7.31	6.75	6.16	5.53	5.18
Tangible Book Value	4,606	4,427	4,058	3,652	3,001	2,775
Tangible Book Value Per Share	6.16	6.49	6.01	5.45	4.78	4.46
Buildings	-	2,411	2,271	2,244	2,078	1,948
Machinery	-	5,128	4,703	4,468	4,011	3,690
Construction In Progress	-	781.1	730.55	545.89	562.96	416.99

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.